Sort
10,766 grants matching “checkpoint inhibitor”
Targeting Cell Death Pathways in Immune-mediated Liver Injury from Checkpoint Inhibitors
$123,750Lily Dara · University Of Southern California · R03 · FY2022 · DK
Targeting Cell Death Pathways in Immune-mediated Liver Injury from Checkpoint Inhibitors
$123,750Lily Dara · University Of Southern California · R03 · FY2023 · DK
Integration of single cell sequencing as a biomarker of PARP inhibitor response for IDH1 and IDH2 mutated AML and MDS
$123,583Patricia M Lorusso · Yale University · UM1 · FY2021 · CA
TARGETING CCR2 TO OVERCOME IMMUNOSUPPRESSION AND IMPROVE IMMUNOTHERAPY
$123,411David G Denardo · Washington University · R21 · FY2014 · CA
NEUROPATHOLOGY/TISSUE BANK CORE
$123,190Claudia Katharina Petritsch · Stanford University · U54 · FY2024 · CA
Translational and Clinical Sciences
$123,142John David Carpten · University Of Southern California · P30 · FY2022 · CA
Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
$123,109Tomas G Neilan · Massachusetts General Hospital · K24 · FY2021 · HL
Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
$123,109Tomas G Neilan · Massachusetts General Hospital · K24 · FY2023 · HL
Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
$123,109Tomas G Neilan · Massachusetts General Hospital · K24 · FY2024 · HL
Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
$123,109Tomas G Neilan · Massachusetts General Hospital · K24 · FY2020 · HL
Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
$123,109Tomas G Neilan · Massachusetts General Hospital · K24 · FY2022 · HL
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer
$122,890Christopher J. Halbrook · University Of Michigan At Ann Arbor · K99 · FY2020 · CA
Ipilimumab as an adjuvant for HIV vaccines
$122,755Mauricio De Aguiar Martins · Scripps Florida · K01 · FY2018 · OD
Proj 4 - Enhancing the Potency and Durability of Immunotherapies
$122,203Crystal L Mackall · Children'S Hosp Of Philadelphia · P01 · FY2021 · CA
Translational and Clinical Sciences
$122,171Heinz Josef Lenz · University Of Southern California · P30 · FY2023 · CA
Cancer Molecular Imaging, Nanotechnology and Theranostics
$121,942Johannes Czernin · University Of California Los Angeles · P30 · FY2020 · CA
Full Project 1: Understanding and Targeting of Convergent Immunosuppressive Pathways and Molecular Signaling in HPV-Positive and HPV-Negative Penile Cancer
$121,939Magaly Martinez-Ferrer · University Of Puerto Rico Med Sciences · U54 · FY2019 · CA
Systematically Investigate Anti-Cancer Drugâs Modulation on T Cells in Tumor Microenvironment
$121,857Yue Wang · University Of Pittsburgh At Pittsburgh · K99 · FY2025 · CA
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients
$121,495Andrew Y Koh · Ut Southwestern Medical Center · K24 · FY2020 · AI
CAREER DEVELOPMENT PROGRAM
$121,438Peter T Scardino · Sloan-Kettering Inst Can Research · P50 · FY2008 · CA
Patient and Community Engagement Core
$121,371Hayley S. Thompson · Wayne State University · P20 · FY2021 · CA
Characterisation and harnessing the CD8+ Tissue Resident Memory T cell response in HPV-driven anal neoplasia.
$121,306Anthony Kelleher · University Of New South Wales · R21 · FY2022 · AI
DNA TOPOISOMERASES &LATE CELL CYCLE CHECKPOINTS
$121,168University Of Calif-Los Alamos Nat Lab · P41 · FY2001 · RR
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$121,055Shruthi Naik · Mayo Clinic Rochester · U01 · FY2025 · CA
Core D: Translational Imaging Core
$120,845Ivan Pedrosa · Ut Southwestern Medical Center · P50 · FY2023 · CA